Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Anika Therapeutics (ANIK) Long-Term Debt Repayments: 2010-2020

Historic Long-Term Debt Repayments for Anika Therapeutics (ANIK) over the last 2 years, with Dec 2020 value amounting to $25.0 million.

  • Anika Therapeutics' Long-Term Debt Repayments was N/A to $25.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $50.8 million, marking a year-over-year change of. This contributed to the annual value of $50.4 million for FY2020, which is N/A change from last year.
  • As of Q4 2020, Anika Therapeutics' Long-Term Debt Repayments stood at $25.0 million, which was down 0.00% from $25.0 million recorded in Q3 2020.
  • Over the past 5 years, Anika Therapeutics' Long-Term Debt Repayments peaked at $25.0 million during Q3 2020, and registered a low of $25.0 million during Q4 2020.
  • Its 1-year average for Long-Term Debt Repayments is $25.0 million, with a median of $25.0 million in 2020.